Catalog # |
Size |
Price |
|
---|---|---|---|
EK-001-01 | 96 wells | $570 |
View/Download (PDF) - for reference only | |||||||||||||||||||||||
| Suggested Procedure | ||||||||||||||||||||||
Measured values represent approximate 'normal' levels in sample, but do not signify the only possible sample levels. Various factors (e.g. sample storage, assay procedure) can affect results. | Human Plasma: 0.68 ng/ml Human Plasma (extracted): 0.49 ng/ml Human Serum: 1.28 ng/ml Human Serum (extracted): 0.24 ng/ml | ||||||||||||||||||||||
| Recommended | ||||||||||||||||||||||
Data may differ slightly based on lot. | 0.12 ng/ml | ||||||||||||||||||||||
Data may differ slightly based on lot. | 0.12 - 1.78 ng/ml | ||||||||||||||||||||||
| |||||||||||||||||||||||
| <10% | ||||||||||||||||||||||
| <15% |
Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3).
Wen JH, Chen YY, Song SJ, et al. Diabetologia. 2009;52(3):504-13.
Stress maladjustment in the pathoetiology of ulcerative colitis.
Kuroki T, Ohta A, Aoki Y, et al. J Gastroenterol. 2007;42(7):522-7.
Rab18 inhibits secretory activity in neuroendocrine cells by interacting with secretory granules.
Vazquez-martinez R, Cruz-garcia D, Duran-prado M, Peinado JR, Castaño JP, Malagon MM. Traffic. 2007;8(7):867-82.
Investigation of the corticotropin-releasing hormone-proopiomelanocortin axis in various skin tumours.
Kim MH, Cho D, Kim HJ, et al. Br J Dermatol. 2006;155(5):910-5.
The role of proopiomelanocortin-derived peptides in skin fibroblast and mast cell functions.
Teofoli P, Frezzolini A, Puddu P, De pità O, Mauviel A, Lotti T. Ann N Y Acad Sci. 1999;885:268-76.
Social Network Confirmation